IRHYTHM TECHNOLOGIES INC. - COMMON STOCK

110,94

13-февраля-25 14:54:48

15 мин. задержка

Акции

-0,23

-0,21%

Сегодняшний диапазон

110,26 - 112,76

ISIN

N/A

Источник

NASDAQ

iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

06 фев 2025 16:05:00 Источник Nasdaq GlobeNewswire
iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference

13 янв 2025 08:30:00 Источник Nasdaq GlobeNewswire
iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

30 дек 2024 16:30:00 Источник Nasdaq GlobeNewswire
iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference

20 ноя 2024 16:30:00 Источник Nasdaq GlobeNewswire
iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring

18 ноя 2024 08:15:00 Источник Nasdaq GlobeNewswire
iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference

05 ноя 2024 16:30:00 Источник Nasdaq GlobeNewswire
iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device

30 окт 2024 17:15:08 Источник Nasdaq GlobeNewswire
iRhythm Technologies Announces Third Quarter 2024 Financial Results

30 окт 2024 16:08:07 Источник Nasdaq GlobeNewswire
Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy

28 окт 2024 08:02:00 Источник Nasdaq GlobeNewswire
iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device

21 окт 2024 16:05:28 Источник Nasdaq GlobeNewswire
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024

16 окт 2024 16:05:00 Источник Nasdaq GlobeNewswire
iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence

11 сен 2024 08:05:00 Источник Nasdaq GlobeNewswire
iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting

09 сен 2024 08:05:00 Источник Nasdaq GlobeNewswire
iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring

04 сен 2024 07:30:00 Источник Nasdaq GlobeNewswire
iRhythm Technologies Announces Results of GUARD-AF Trial

01 сен 2024 13:33:00 Источник Nasdaq GlobeNewswire
iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain

29 авг 2024 08:00:00 Источник Nasdaq GlobeNewswire
iRhythm Technologies to Participate in Upcoming Investor Conferences in September

21 авг 2024 16:05:00 Источник Nasdaq GlobeNewswire
iRhythm Technologies Announces Chief Financial Officer Transition

01 авг 2024 16:06:00 Источник Nasdaq GlobeNewswire
iRhythm Technologies Announces Second Quarter 2024 Financial Results

01 авг 2024 16:05:00 Источник Nasdaq GlobeNewswire
iRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024

18 июл 2024 16:05:00 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.